Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedIntroduced a consolidated Locations section listing multiple sites across the United States and England, replacing the previous state-specific location entries.SummaryDifference0.9%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed, and a Revision: v3.3.2 tag was added; the previous PubMed description and Revision: v3.2.0 tag were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedNotice about government funding lapse and NIH operating status was removed. The previous notice informed users that information may not be up to date and directed users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.3%

- Check63 days agoChange DetectedResults data for the study were posted on the page, including outcome measures and updated study record dates. The update provides accessible information on the trial outcomes directly within the study record.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference3%

- Check100 days agoChange DetectedUpdated terminology to Squamous cell carcinoma of the head and neck and bumped the revision to v3.1.0, reflecting a terminology update and new version. Earlier term Head and neck squamous cell carcinoma and revision v3.0.2 were removed.SummaryDifference0.6%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.